Daily Archives: March 30, 2016

Once and Future AdComms Affecting Drug Applications

One area of FDA activity that I like to track is in relation to advisory committees which I think provide us with something of a surrogate marker for the pace at which FDA is considering and approving new drugs. To … Continue reading

Posted in Advisory Committee Prepapartion | Comments Off on Once and Future AdComms Affecting Drug Applications